Literature DB >> 12791897

Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci.

Daniel J Diekema1, Janet I Andrews, Holly Huynh, Paul R Rhomberg, Stella R Doktor, Jill Beyer, Virginia D Shortridge, Robert K Flamm, Ronald N Jones, Michael A Pfaller.   

Abstract

Pulsed-field gel electrophoresis (PFGE) was performed on 122 neonatal bloodstream isolates of group B streptococci (GBS) to further examine the relationship between macrolide resistance and serotype V GBS (GBS-V). Over one-third (35%) of macrolide-resistant GBS belonged to a single PFGE subtype of GBS-V, which was also the most common GBS-V subtype noted in previous Centers for Disease Control and Prevention surveillance studies. Erm methylase (ermA and ermB) was the most common resistance mechanism detected, present in 12 of 20 macrolide-resistant GBS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791897      PMCID: PMC156484          DOI: 10.1128/JCM.41.6.2659-2661.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study.

Authors:  D De Mouy; J D Cavallo; R Leclercq; R Fabre
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Mechanisms of macrolide resistance in clinical group B streptococci isolated in France.

Authors:  F Fitoussi; C Loukil; I Gros; O Clermont; P Mariani; S Bonacorsi; I Le Thomas; D Deforche; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  The changing spectrum of group B streptococcal disease.

Authors:  M R Wessels; D L Kasper
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

5.  Emergence of serotype V group B streptococcal infection among infants and adults.

Authors:  L H Harrison; D M Dwyer; J A Johnson
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

6.  Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups.

Authors:  D F Zaleznik; M A Rench; S Hillier; M A Krohn; R Platt; M L Lee; A E Flores; P Ferrieri; C J Baker
Journal:  Clin Infect Dis       Date:  2000-02       Impact factor: 9.079

7.  Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae.

Authors:  Esther Culebras; Iciar Rodriguez-Avial; Carmen Betriu; Montserrat Redondo; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

8.  Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.

Authors:  J C de Azavedo; M McGavin; C Duncan; D E Low; A McGeer
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

9.  Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.

Authors:  J I Andrews; D J Diekema; S K Hunter; P R Rhomberg; M A Pfaller; R N Jones; G V Doern
Journal:  Am J Obstet Gynecol       Date:  2000-10       Impact factor: 8.661

10.  Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women.

Authors:  Shannon D Manning; Betsy Foxman; Carl L Pierson; Patricia Tallman; Carol J Baker; Mark D Pearlman
Journal:  Obstet Gynecol       Date:  2003-01       Impact factor: 7.661

View more
  18 in total

1.  Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.

Authors:  V Lavergne; M Laverdière; A Duchesne; C Béliveau; J Delorme; A Di Zazzo; A C Labbé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

2.  Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources.

Authors:  Rafael S Duarte; Bruna C Bellei; Otávio P Miranda; Maria A V P Brito; Lúcia M Teixeira
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae.

Authors:  José María Marimón; Adoración Valiente; María Ercibengoa; José M García-Arenzana; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal.

Authors:  E R Martins; J Melo-Cristino; M Ramirez
Journal:  J Clin Microbiol       Date:  2012-01-04       Impact factor: 5.948

5.  Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy.

Authors:  M A De Francesco; S Caracciolo; F Gargiulo; N Manca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-26       Impact factor: 3.267

Review 6.  Laboratory detection of group B Streptococcus for prevention of perinatal disease.

Authors:  F J Picard; M G Bergeron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-16       Impact factor: 3.267

7.  Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea.

Authors:  Young Uh; In Ho Jang; Gyu Yel Hwang; Mi Kyung Lee; Kap Jun Yoon; Hyo Youl Kim
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae.

Authors:  Young Uh; Hyo Youl Kim; In Ho Jang; Gyu Yel Hwang; Kap Jun Yoon
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

9.  Isolation of quinupristin/dalfopristin-resistant Streptococcus agalactiae from asymptomatic Korean women.

Authors:  Hye Ran Nam; Hak Mee Lee; Yeonhee Lee
Journal:  J Microbiol       Date:  2008-02       Impact factor: 3.422

10.  Telithromycin susceptibility and genomic diversity of macrolide-resistant serotype III group B streptococci isolated in perinatal infections.

Authors:  Edouard Bingen; Catherine Doit; Philippe Bidet; Naima Brahimi; Dominique Deforche
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.